Substituted isoquinolinones

Details for Australian Patent Application No. 2004279809 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Marlowe, Charles K.; Smyth, Mark S.; Kane-Maguire, Kim A.; Zhang, Xiaoming; Scarborough, Robert M.

Agent Pizzeys

Pub. Number AU-B-2004279809

PCT Pub. Number WO2005/035520

Priority 60/508,402 03.10.03 US

Filing date 29 September 2004

Wipo publication date 21 April 2005

Acceptance publication date 15 July 2010

International Classifications

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/035520 Priority application(s): WO2005/035520

15 July 2010 Application Accepted

  Published as AU-B-2004279809

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279810-Single nucleotide polymorphism analysis of highly polymorphic target sequences

2004279808-Process for the preparation of N-amino substituted heterocyclic compounds